4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001140361-22-001654
10% owner bought 2,300,000 shares at $19.00 ($43,700,000)
- 10% owner acquired 4,870,536 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP 10% owner | 2022-01-11 | Conversion | +4,870,536 | 4,870,536 | I: show line 1 in the form | ||
| VIKING GLOBAL INVESTORS LP 10% owner | 2022-01-11 | Purchase | +2,300,000 | $19.00 | $43,700,000 | 2,300,000 | I: show line 2 in the form |
| Open-market purchases · 2,300,000 sh · avg $19.00 · $43,700,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP 10% owner | 2022-11-11 | Conversion · Series C-1 Preferred Stock | −4,870,536 | 0 | I: show line 3 in the form |
Loading xslF345X03/form4.xml…